Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33

QR Code

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33

Angela J Okragly,1 Katie Brannon Corwin,2 Marikka Elia,3 Dongmei He,3 Oliver Schroeder,3 Qing Zhang,3 Tatiyana Shiyanova,2 Stuart Bright,1 Sarah B Dicker,4 Lukasz Chlewicki,4 Stephanie ME Truhlar,3 Julian Davies,3 Chetan N Patel,2 Robert J Benschop1 1Immunology Research, Eli Lilly and Company, India...

Full description

Saved in:

Bibliographic Details
Main Authors:	Okragly AJ, Corwin KB, Elia M, He D, Schroeder O, Zhang Q, Shiyanova T, Bright S, Dicker SB, Chlewicki L, Truhlar SME, Davies J, Patel CN, Benschop RJ
Format:	article
Language:	EN
Published:	Dove Medical Press 2021
Subjects:	il-33 th2 immune response monoclonal antibody Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Online Access:	https://doaj.org/article/fd8ca8b2a5a9428db12b98a7dd6bcfef
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Monoclonal antibodies in immunodiagnosis and immunotherapy

Anticuerpo monoclonal anti-inmunoglobulina E en el tratamiento de la rinitis alérgica
by: Naser G,Alfredo, et al.
Published: (2011)

Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
by: Ivan Gentile, et al.
Published: (2021)

COMPARATIVE STUDY OF “KLIM-TEST” MONOCLONAL ANTIBODIES FOR PHENOTYPING OF PERIPHERAL BLOOD CELLS WITH MONOCLONALS FROM FOREIGN PRODUCERS
by: A. A. Popova, et al.
Published: (2014)

Utilización de un anticuerpo monoclonal en el diagnóstico directo e indirecto del virus IPN en peces infectados experimentalmente
by: CIFUENTES,F., et al.
Published: (1999)

Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
by: Elsbernd PM, et al.
Published: (2021)

Casirivimab and imdevimab as investigational monoclonal antibodies for COVID-19 patients – review of the literature
by: Reka Gabriela, et al.
Published: (2021)

Uso del rituximab(anticuerpo monoclonal anti-CD20) en lupus eritematoso sistémico refractario a tratamiento: Caso clínico
by: Sabugo S,Francisca, et al.
Published: (2005)

Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
by: Singh SK, et al.
Published: (2018)

The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
by: Daniela Luz, et al.
Published: (2021)

Eficacia y seguimiento en el largo plazo de pacientes con psoriasis vulgar moderada a severa en tratamiento con infliximab (Remicade®)
by: Valdés A,María del Pilar, et al.
Published: (2006)

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
by: Abuasab T, et al.
Published: (2021)

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
by: Navalkele BD, et al.
Published: (2018)

Production of monoclonal antibodies against AFLM (Ver-1), a middle key protein involved in aflatoxin biosynthesis
by: Ting Wang, et al.
Published: (2021)

Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy
by: Yoon K. Cohen, et al.
Published: (2015)

Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
by: AVILA,ANA D, et al.
Published: (2007)

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
by: Nayanendu Saha, et al.
Published: (2022)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
by: Laurel Goldin, et al.
Published: (2021)

Concurrent monoclonal gammopathy and systemic lupus erythematosus in a known case of ulcerative colitis: A case report
by: Mahan Shafie, et al.
Published: (2021)

Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
by: Akiko Kumagai, et al.
Published: (2021)

Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
by: Luis Puig, et al.
Published: (2021)

Development of an immunochromatographic strip assay for three major capsaicinoids based on an ultrasensitive monoclonal antibody
by: Jiajia Sun, et al.
Published: (2018)

Hexon-based scaffold for generation of diagnostic monoclonal antibodies against diverse adenovirus types
by: T. A. Timoshicheva, et al.
Published: (2019)

A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
by: Syed Mohammed Basheeruddin Asdaq, et al.
Published: (2021)

Preparation of polyclonal and monoclonal anti-idiotypic antibodies against morphine-specific immunoglobulins
by: A. V. Trofimov, et al.
Published: (2020)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
by: Anne-Cathrine S. Vogt, et al.
Published: (2021)

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
by: Cazzola M, et al.
Published: (2021)

In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
by: Silvere Pagant, et al.
Published: (2021)

PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
by: Liu L, et al.
Published: (2016)

Global Market of Monoclonal Antibodies: Sales, Prices, Demand
by: D. A. Uvarov
Published: (2021)

Quantitative <i>N-</i>Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis
by: Bastiaan L. Duivelshof, et al.
Published: (2021)

PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
by: Xu S, et al.
Published: (2018)

Human antibodies
Published: (1997)

New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by <named-content content-type="genus-species">Enterobacter cloacae</named-content> and Their Use in Analysis of Human Serum
by: Craig Skinner, et al.
Published: (2016)

EXPRESS-DIAGNOSTIC OF RUBELLA INFECTION BY THE IMMUNOFLUORESCENT ASSAY USING MONOCLONAL ANTIBODIES TO PROTEIN E1 OF RUBELLA VIRUS
by: A. N. Lisakov, et al.
Published: (2014)

Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report
by: Ayham Daher, et al.
Published: (2021)

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
by: Chrysi Galigalidou, et al.
Published: (2021)

ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
by: E. V. Voronina, et al.
Published: (2018)

Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
by: Omar M. Ismail, et al.
Published: (2021)